WeVote
Log In

Bill

Bill

HB 2752

Setting standards for patient and caregiver identification cards to ensure legal access to medical cannabis, establishing the Kansas medical cannabis agency within the department of health and environment and removing cannabis from the Kansas uniform controlled substances act.

2025-2026 Regular Session

Creates a state regulatory framework for medical cannabis, led by the Kansas Medical Cannabis Agency within KDHE, separate from the UCSA, with patient/caregiver ID cards.

Died in Committee
#cannabis #crimes #punishmentandcriminalprocedure #discrimination #funds #healthandenvironment #departmentof #healthandhealthcare #namedacts #taxation
0
WeVote Research Nonpartisan
Bill Summary · HB 2752

Overview

HB 2752 (Kansas, 2025-2026) would address medical cannabis policy and administration by:

  • Setting standards for patient and caregiver identification cards to ensure legal access to medical cannabis.
  • Establishing the Kansas Medical Cannabis Agency within the Department of Health and Environment (KDHE).
  • Removing cannabis from the Kansas Uniform Controlled Substances Act (UCSA), effectively reclassifying it within state law.
  • The bill progressed to committee but died in committee as of the latest action.

Purpose and intent

  • Create a formal regulatory framework to govern medical cannabis access for patients and their caregivers.
  • Centralize oversight and administration of medical cannabis programs under a dedicated state agency housed in KDHE.
  • Clarify and standardize the identification process for patients and primary caregivers to support lawful possession and use of medical cannabis.
  • Remove cannabis from the state’s UCSA, signaling a shift in how cannabis is regulated (no longer treated as a controlled substance under the UCSA) and enabling separate, program-specific rules.

Key provisions and changes

  1. Identification cards

    • Establish firm standards for the issuance and use of patient and caregiver identification cards.
    • Aims to ensure that individuals participating in the medical cannabis program can demonstrate lawful eligibility at points of sale, transport, and use.

  2. Administration and agency structure

    • Create or designate the Kansas Medical Cannabis Agency within the Department of Health and Environment.
    • Define the agency’s duties, which may include licensing, program administration, quality control, and enforcement related to medical cannabis (subject to the bill’s specifics).

  3. Regulatory status of cannabis

    • Remove cannabis from the Kansas Uniform Controlled Substances Act.
    • Lead to the creation of separate regulatory pathways, potentially including licensing, cultivation/production controls, dispensary operations, medical registry management, and patient protections that are distinct from the UCSA framework.

  4. Program scope and protections (as typically contemplated in such bills)

    • Eligibility criteria for patients and caregivers (e.g., qualifying medical conditions, diagnosis requirements).
    • Registration processes, renewals, and card validity periods.
    • Safeguards against abuse, diversion, and sale to non-eligible individuals.
    • Privacy protections for patient information.
    • Fees associated with card issuance, renewal, and program operation (if specified).

  5. Implementation timeline

    • The bill would outline timing for establishing the agency, implementing registration, and transitioning cannabis regulation away from the UCSA (if applicable).
    • Given the action history, the legislation progressed to committee but did not become law in the 2025-2026 session.

Affected parties and impacts

  • Patients and caregivers: Eligible individuals would obtain state-issued identification cards to access medical cannabis legally and participate in the program.
  • Healthcare providers: Providers would support qualifying patients and may interact with the registry/identification process.
  • KDHE and Kansas Medical Cannabis Agency: Responsible for program administration, licensing, compliance, and enforcement.
  • Cannabis-related businesses: Dispensaries or cultivators (depending on the final program design) would operate under a separate regulatory framework aligned with the agency’s rules.
  • General public: Policies affecting enforcement, reporting, tax implications, and public health considerations.

Procedural and timeline aspects

  • Introduction and referral: HB 2752 was introduced and referred to the House Committee on Federal and State Affairs on February 6, 2026.
  • Committee action: The bill progressed to committee but ultimately died in committee on April 10, 2026.
  • Implication: No floor vote or enactment occurred in the 2025-2026 session; the provisions would require reintroduction and potential amendment to move forward in a future session.

Notes

  • The summary reflects the bill’s stated aims and the action history provided. Specific details such as exact eligibility criteria, fee amounts, regulatory duties for the agency, and enforcement mechanisms would appear in the bill text and any subsequent amendments.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.